Karen Hunter Cohn
Scientific Advisor @Celmatix Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Scientific Advisor @Celmatix Therapeutics
NY, US
Celmatix is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead program in ovarian senescence and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health.
EDUCATION
Gerstner Sloan Kettering Graduate School of Biomedical Sciences at Memorial Sloan Kettering Cancer Center
PhD, Cancer Biology
Massachusetts Institute of Technology
Dual BS, Chemical Engineering and Biology; Concentration Area: Economics
ABOUT KAREN HUNTER COHN
Mission-driven PhD scientist and problem solver passionate about translating innovative research into applications that make an impact on patients with high unmet need. Expertise in building and interrogating real-world datasets, human genetics-driven approaches to drug discovery, and drug development. Broad expertise across therapeutic areas with deep expertise in fertility, women’s health, and oncology.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.